Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease

Experimental Neurology
Volume 298, Part B, December 2017, Pages 137-147

Quote:

---

Two newer neurotrophic factors currently being pursued for clinical application are the mesencephalic astrocyte-derived neurotrophic factor (MANF) and the ...

---

For those that might have access:

http://www.sciencedirect.com/science/article/...8617302431